keyword
https://read.qxmd.com/read/38701782/small-molecule-induced-epigenetic-rejuvenation-promotes-srebp-condensation-and-overcomes-barriers-to-cns-myelin-regeneration
#21
JOURNAL ARTICLE
Xuezhao Liu, Dazhuan Eric Xin, Xiaowen Zhong, Chuntao Zhao, Zhidan Li, Liguo Zhang, Adam J Dourson, Lindsay Lee, Shreya Mishra, Arman E Bayat, Eva Nicholson, William L Seibel, Bingfang Yan, Joel Mason, Bradley J Turner, David G Gonsalvez, William Ong, Sing Yian Chew, Balaram Ghosh, Sung Ok Yoon, Mei Xin, Zhigang He, Jason Tchieu, Michael Wegner, Klaus-Armin Nave, Robin J M Franklin, Ranjan Dutta, Bruce D Trapp, Ming Hu, Matthew A Smith, Michael P Jankowski, Samantha K Barton, Xuelian He, Q Richard Lu
Remyelination failure in diseases like multiple sclerosis (MS) was thought to involve suppressed maturation of oligodendrocyte precursors; however, oligodendrocytes are present in MS lesions yet lack myelin production. We found that oligodendrocytes in the lesions are epigenetically silenced. Developing a transgenic reporter labeling differentiated oligodendrocytes for phenotypic screening, we identified a small-molecule epigenetic-silencing-inhibitor (ESI1) that enhances myelin production and ensheathment...
April 25, 2024: Cell
https://read.qxmd.com/read/38701697/evaluating-the-utility-of-serum-nfl-gfap-uchl1-and-ttau-as-estimates-of-csf-levels-and-diagnostic-instrument-in-neuroinflammation-and-multiple-sclerosis
#22
JOURNAL ARTICLE
Kimberly Koerbel, Michelle Maiworm, Martin Schaller-Paule, Jan Hendrik Schäfer, Jasmin Jakob, Lucie Friedauer, Falk Steffen, Stefan Bittner, Christian Foerch, Yavor Yalachkov
BACKGROUND: This study aimed to evaluate the utility of neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), ubiquitin C-terminal hydrolase L1 (UCHL1) and total tau (tTAU) serum concentrations as approximation for cerebrospinal fluid (CSF) concentrations of the respective biomarkers in the context of neuroinflammation and multiple sclerosis (MS). METHODS: NfL, GFAP, UCHL1 and tTAU concentrations in serum and CSF were measured in 183 patients (122 with neuroinflammatory disease and 61 neurological or somatoform disease controls) using the single molecule array HD-1 analyzer (Quanterix, Boston, MA)...
April 26, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38701636/improving-multiple-sclerosis-lesion-segmentation-across-clinical-sites-a-federated-learning-approach-with-noise-resilient-training
#23
JOURNAL ARTICLE
Lei Bai, Dongang Wang, Hengrui Wang, Michael Barnett, Mariano Cabezas, Weidong Cai, Fernando Calamante, Kain Kyle, Dongnan Liu, Linda Ly, Aria Nguyen, Chun-Chien Shieh, Ryan Sullivan, Geng Zhan, Wanli Ouyang, Chenyu Wang
Accurately measuring the evolution of Multiple Sclerosis (MS) with magnetic resonance imaging (MRI) critically informs understanding of disease progression and helps to direct therapeutic strategy. Deep learning models have shown promise for automatically segmenting MS lesions, but the scarcity of accurately annotated data hinders progress in this area. Obtaining sufficient data from a single clinical site is challenging and does not address the heterogeneous need for model robustness. Conversely, the collection of data from multiple sites introduces data privacy concerns and potential label noise due to varying annotation standards...
April 17, 2024: Artificial Intelligence in Medicine
https://read.qxmd.com/read/38701570/combined-in-vivo-effect-of-n-acylethanolamine-hydrolyzing-acid-amidase-and-glycogen-synthase-kinase-3%C3%AE-inhibition-to-treat-multiple-sclerosis
#24
JOURNAL ARTICLE
Stefania Sgroi, Elisa Romeo, Ennio Albanesi, Federica Piccardi, Federico Catalano, Doriana Debellis, Fabio Bertozzi, Angelo Reggiani
The current pharmacological approaches to multiple sclerosis (MS) target its inflammatory and autoimmune components, but effective treatments to foster remyelination and axonal repair are still lacking. We therefore selected two targets known to be involved in MS pathogenesis: N-acylethanolamine-hydrolyzing acid amidase (NAAA) and glycogen synthase kinase-3β (GSK-3β). We tested whether inhibiting these targets exerted a therapeutic effect against experimental autoimmune encephalomyelitis (EAE), an animal model of MS...
May 2, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38701190/a-t-h-17-intrinsic-il-1%C3%AE-stat5-axis-drives-steroid-resistance-in-autoimmune-neuroinflammation
#25
JOURNAL ARTICLE
William A Miller-Little, Xing Chen, Vanessa Salazar, Caini Liu, Katarzyna Bulek, Julie Y Zhou, Xiao Li, Olaf Stüve, Thaddeus Stappenbeck, George Dubyak, Junjie Zhao, Xiaoxia Li
Steroid resistance poses a major challenge for the management of autoimmune neuroinflammation. T helper 17 (TH 17) cells are widely implicated in the pathology of steroid resistance; however, the underlying mechanisms are unknown. In this study, we identified that interleukin-1 receptor (IL-1R) blockade rendered experimental autoimmune encephalomyelitis (EAE) mice sensitive to dexamethasone (Dex) treatment. Interleukin-1β (IL-1β) induced a signal transducer and activator of transcription 5 (STAT5)-mediated steroid-resistant transcriptional program in TH 17 cells, which promoted inflammatory cytokine production and suppressed Dex-induced anti-inflammatory genes...
May 3, 2024: Science Immunology
https://read.qxmd.com/read/38701189/oxidative-phosphorylation-regulates-b-cell-effector-cytokines-and-promotes-inflammation-in-multiple-sclerosis
#26
JOURNAL ARTICLE
Rui Li, Yanting Lei, Ayman Rezk, Diego A Espinoza, Jing Wang, Huiru Feng, Bo Zhang, Isabella P Barcelos, Hang Zhang, Jing Yu, Xinrui Huo, Fangyi Zhu, Changxin Yang, Hao Tang, Amy C Goldstein, Brenda L Banwell, Hakon Hakonarson, Hongwei Xu, Michael Mingueneau, Bo Sun, Hulun Li, Amit Bar-Or
Dysregulated B cell cytokine production contributes to pathogenesis of immune-mediated diseases including multiple sclerosis (MS); however, the underlying mechanisms are poorly understood. In this study we investigated how cytokine secretion by pro-inflammatory (GM-CSF-expressing) and anti-inflammatory (IL-10-expressing) B cells is regulated. Pro-inflammatory human B cells required increased oxidative phosphorylation (OXPHOS) compared with anti-inflammatory B cells. OXPHOS reciprocally modulated pro- and anti-inflammatory B cell cytokines through regulation of adenosine triphosphate (ATP) signaling...
May 3, 2024: Science Immunology
https://read.qxmd.com/read/38701142/associations-between-neuroinflammation-related-conditions-and-alzheimer-s-disease-a-study-of-us-insurance-claims-data
#27
JOURNAL ARTICLE
Jing Xu, Yao Chen, Yi Shi, Anna Sun, Yuedi Yang, Malaz Boustani, Jing Su, Pengyue Zhang
BACKGROUND: Early detection of Alzheimer's disease (AD) is a key component for the success of the recently approved lecanemab and aducanumab. Patients with neuroinflammation-related conditions are associated with a higher risk for developing AD. OBJECTIVE: Investigate the incidence of AD among patients with neuroinflammation-related conditions including epilepsy, hemorrhage stroke, multiple sclerosis (MS), and traumatic brain injury (TBI). METHODS: We used Optum's de-identified Clinformatics Data Mart Database (CDM)...
April 30, 2024: Journal of Alzheimer's Disease: JAD
https://read.qxmd.com/read/38701025/the-landscape-of-real-world-evidence-of-rituximab-utilization-and-clinical-outcomes-in-patients-with-cancer-rheumatoid-arthritis-and-multiple-sclerosis-a-scoping-review
#28
REVIEW
Kevin H Li, Mohammad Kaker, Jerry Lau, Kyle Noonan, Stephanie Zhang, Cara L McDermott, Catherine M Lockhart
BACKGROUND: Rituximab (RTX) is an anti-CD20 monoclonal antibody that is used to treat various conditions in cancer, rheumatoid arthritis (RA), and multiple sclerosis (MS). Although RTX has been used in the United States for almost 3 decades, questions remain regarding its real-world utilization and effectiveness. OBJECTIVE: To describe the state of observational research and real-world evidence evaluating RTX in oncology, RA, and off-label use in MS. METHODS: A broad search was conducted in MEDLINE, Embase, and CINAHL covering the period of January 2010 to June 2022...
May 2024: Journal of Managed Care & Specialty Pharmacy
https://read.qxmd.com/read/38700598/a-systematic-review-to-explore-patients-ms-knowledge-and-ms-risk-knowledge
#29
REVIEW
Edward Smith, Dawn Langdon
Living with a chronic illness poses particular challenges, including maintaining current disease knowledge to optimise self-management and interaction with health professionals. People with Multiple Sclerosis (MS) are increasingly encouraged to participate in shared decision making. Making informed decisions is likely to rely on adequate knowledge about the condition and its associated risks. The aim of this systematic review is to explore patients' existing MS knowledge and MS risk knowledge, and how these relate to demographic and disease variables...
May 3, 2024: Neurological Sciences
https://read.qxmd.com/read/38700322/serum-neurofilament-light-chain-and-glial-fibrillary-acidic-protein-for-predicting-response-to-apheresis-in-steroid-refractory-multiple-sclerosis-relapses
#30
JOURNAL ARTICLE
Ioannis Vardakas, Johannes Dorst, André Huss, Benjamin Mayer, Tanja Fangerau, Daniela Taranu, Hayrettin Tumani, Makbule Senel
BACKGROUND AND PURPOSE: The predictive value of serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) for apheresis outcome in steroid-refractory multiple sclerosis (MS) relapse has not yet been evaluated. METHODS: We used pre- and postapheresis serum samples from 38 participants of the IAPEMS trial (clinicaltrials.gov: NCT02671682), which investigated the use of immunoadsorption versus plasma exchange for the treatment of steroid-refractory MS attacks...
May 3, 2024: European Journal of Neurology
https://read.qxmd.com/read/38700207/nuclear-and-degradative-functions-of-the-escrt-iii-pathway-implications-for-neurodegenerative-disease
#31
REVIEW
Olivia Keeley, Alyssa N Coyne
The ESCRT machinery plays a pivotal role in membrane-remodeling events across multiple cellular processes including nuclear envelope repair and reformation, nuclear pore complex surveillance, endolysosomal trafficking, and neuronal pruning. Alterations in ESCRT-III functionality have been associated with neurodegenerative diseases including Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS), and Alzheimer's Disease (AD). In addition, mutations in specific ESCRT-III proteins have been identified in FTD/ALS...
December 2024: Nucleus
https://read.qxmd.com/read/38699700/determination-of-systemic-inflammatory-biomarkers-in-multiple-sclerosis
#32
JOURNAL ARTICLE
Maša Sladojević, Stanislava Nikolić, Željko Živanović, Svetlana Simić, Lorand Sakalaš, Igor Spasić, Branislava Ilinčić, Velibor Čabarkapa
BACKGROUND: Multiple sclerosis (MS) is one of the most common demyelinating diseases of the central nervous system. We aimed to investigate serum and cerebrospinal fluid levels of different laboratory inflammatory biomarkers in patients with MS. METHODS: A total of 120 subjects participated in the study, 60 of whom were diagnosed with MS, 30 with the final diagnosis of non-inflammatory diseases of the central nervous system (CNS), and 30 healthy subjects representing the control group...
April 23, 2024: Journal of Medical Biochemistry
https://read.qxmd.com/read/38699321/cerebellar-volume-measures-may-differentiate-multiple-sclerosis-fallers-from-non-fallers
#33
Taylor N Takla, Jennie Feldpausch, Erin M Edwards, Shuo Han, Peter A Calabresi, Jerry Prince, Kathleen M Zackowski, Nora E Fritz
Introduction: The cerebellum is a common lesion site in persons with multiple sclerosis (PwMS). Physiologic and anatomic studies have identified a topographic organization of the cerebellum including functionally distinct motor and cognitive areas. This study implemented a recent parcellation algorithm developed by Han et al., 2020 to a sample of PwMS and healthy controls to examine relationships among specific cerebellar regions, fall status, and common clinical measures of motor and cognitive functions. Methods: Thirty-one PwMS and 29 age and sex-matched controls underwent an MRI scan and motor and cognitive testing...
April 19, 2024: Research Square
https://read.qxmd.com/read/38699050/hypogammaglobulinemia-and-infections-in-patients-with-multiple-sclerosis-treated-with-anti-cd20-treatments-a-systematic-review-and-meta-analysis-of-19-139-multiple-sclerosis-patients
#34
Anas Elgenidy, Nagham Nader Abdelhalim, Mohammed Al-Mahdi Al-Kurdi, Lobna A Mohamed, Mohamed M Ghoneim, Ahmed Wagdy Fathy, Hazem Khaled Hassaan, Ahmed Anan, Omar Alomari
BACKGROUND: Recent years have seen the emergence of disease-modifying therapies in multiple sclerosis (MS), such as anti-cluster of differentiation 20 (anti-CD20) monoclonal antibodies, aiming to modulate the immune response and effectively manage MS. However, the relationship between anti-CD20 treatments and immunoglobulin G (IgG) levels, particularly the development of hypogammaglobulinemia and subsequent infection risks, remains a subject of scientific interest and variability. We aimed to investigate the intricate connection between anti-CD20 MS treatments, changes in IgG levels, and the associated risk of hypogammaglobulinemia and subsequent infections...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38698901/virtual-brain-twins-from-basic-neuroscience-to-clinical-use
#35
REVIEW
Huifang E Wang, Paul Triebkorn, Martin Breyton, Borana Dollomaja, Jean-Didier Lemarechal, Spase Petkoski, Pierpaolo Sorrentino, Damien Depannemaecker, Meysam Hashemi, Viktor K Jirsa
Virtual brain twins are personalized, generative and adaptive brain models based on data from an individual's brain for scientific and clinical use. After a description of the key elements of virtual brain twins, we present the standard model for personalized whole-brain network models. The personalization is accomplished using a subject's brain imaging data by three means: (1) assemble cortical and subcortical areas in the subject-specific brain space; (2) directly map connectivity into the brain models, which can be generalized to other parameters; and (3) estimate relevant parameters through model inversion, typically using probabilistic machine learning...
May 2024: National Science Review
https://read.qxmd.com/read/38698620/investigating-disparities-in-smoking-cessation-treatment-for-veterans-with-multiple-sclerosis-a-national-analysis
#36
JOURNAL ARTICLE
Carri S Polick, Paul Dennis, Patrick S Calhoun, Tiffany J Braley, Eunice Lee, Sarah Wilson
BACKGROUND AND AIMS: Smoking is a risk factor for multiple sclerosis (MS) development, symptom burden, decreased medication efficacy, and increased disease-related mortality. Veterans with MS (VwMS) smoke at critically high rates; however, treatment rates and possible disparities are unknown. To promote equitable treatment, we aim to investigate smoking cessation prescription practices for VwMS across social determinant factors. METHODS: We extracted data from the national Veterans Health Administration electronic health records between October 1, 2017, and September 30, 2018...
May 2024: Brain and Behavior
https://read.qxmd.com/read/38698454/lifestyle-management-and-brain-mri-metrics-in-female-australian-adults-living-with-multiple-sclerosis-a-feasibility-and-acceptability-study
#37
JOURNAL ARTICLE
Olivia Wills, Brooklyn Wright, Lisa-Marie Greenwood, Nadia Solowij, Mark Schira, Jerome J Maller, Alok Gupta, John Magnussen, Yasmine Probst
BACKGROUND: Limited studies of multiple sclerosis (MS) exist whereby magnetic resonance imaging (MRI) of the brain with consistent imaging protocols occurs at the same time points as collection of healthy lifestyle measures. The aim of this study was to test the feasibility, acceptability and preliminary efficacy of acquiring MRI data as an objective, diagnostic and prognostic marker of MS, at the same time point as brain-healthy lifestyle measures including diet. METHODS: Participants living with relapsing remitting MS partook in one structural MRI scanning session of the brain, completed two online 24-hour dietary recalls and demographic and self-reported lifestyle questionnaires (e...
May 2, 2024: Pilot and Feasibility Studies
https://read.qxmd.com/read/38698450/risk-factors-and-long-term-outcomes-of-oropharyngeal-dysphagia-in-persons-with-multiple-sclerosis-a-systematic-review-protocol
#38
JOURNAL ARTICLE
Zahra Sadeghi, Mohamadreza Afshar, Asefeh Memarian, Heather L Flowers
BACKGROUND: Oropharyngeal dysphagia (OPD) can be functionally debilitating in persons with multiple sclerosis (pwMS). OPD induces alterations in safety and efficiency of food and/or liquid ingestion and may incur negative sequalae such as aspiration pneumonia or malnutrition/dehydration. Early detection and timely management of OPD in pwMS could prevent such complications and reduce mortality rates. Identifying risk factors of OPD relative to its onset or repeat manifestation will enable the development of care pathways that target early assessment and sustained management...
May 2, 2024: Systematic Reviews
https://read.qxmd.com/read/38697612/comparison-between-r2-based-and-r2-based-%C3%AF-separation-methods-a-clinical-evaluation-in-individuals-with-multiple-sclerosis
#39
JOURNAL ARTICLE
Sooyeon Ji, Jinhee Jang, Minjun Kim, Hyebin Lee, Woojun Kim, Jongho Lee, Hyeong-Geol Shin
Susceptibility source separation, or χ-separation, estimates diamagnetic (χdia ) and paramagnetic susceptibility (χpara ) signals in the brain using local field and R2' (= R2* - R2) maps. Recently proposed R2*-based χ-separation methods allow for χ-separation using only multi-echo gradient echo (ME-GRE) data, eliminating the need for additional data acquisition for R2 mapping. Although this approach reduces scan time and enhances clinical utility, the impact of missing R2 information remains a subject of exploration...
May 2, 2024: NMR in Biomedicine
https://read.qxmd.com/read/38697017/assessment-of-serum-inflammatory-parameters-in-rrms-and-spms-patients
#40
JOURNAL ARTICLE
Maria Nowak-Kiczmer, Natalia Niedziela, Zenon P Czuba, Paweł Sowa, Krzysztof Wierzbicki, Michał Lubczyński, Monika Adamczyk-Sowa
OBJECTIVES: Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease. Patients with relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS) differ in their responses to treatment; therefore, the correct diagnosis of the particular type of MS is crucial, and biomarkers that can differentiate between the forms of MS need to be identified. The aim of this study was to compare the levels of inflammatory parameters in serum samples from patients with RRMS and SPMS. METHODS: The study group consisted of 60 patients with diagnosed MS...
May 2, 2024: Neurological Research
keyword
keyword
170755
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.